ACE and diabetes mellitus: Discharge medications included aspirin in 97.3%, β-Blockers in 81.9%, ACE inhibitors/ARBs in 83.7%, and statins in 93.7% of the study population and did not differ between patients with and without DM (p = 0.999, p = 0.134, p = 0.626 and p = 0.270 respectively).